Wang W, Liu B, Sun S, et al. Onco Targets Ther. 2020;13:1649–1659.
The authors have advised due to an error at the time of figure assembly, duplicate images were used in Figure 1E on page 1652.
Figure 1.
Continued.
The correct Figure 1 is shown below. This error does not affect the results of the paper. The authors apologize for this error.
Figure 1.
Downregulation ofmiR-486-5p enhanced the cytotoxic effect of 5-Fu in pancreatic cancer cells. (A) PANC-1 and (B) MiaPaCa-2 cells were transfected with 10 nMmiR-486-5p agonist or 10 nMmiR-486-5p antagonist for 48 hrs. RT-qPCR was used to detect the level ofmiR-486-5p in PANC-1 and MiaPaCa-2 cells. (C) PANC-1 and (D) MiaPaCa-2 cells were transfected with 10 nM miR-486-5p antagonist, and then exposed to 5-Fu for 48 hrs. Cell Counting Kit 8 assay was used to determine the cell viability. (E, F) PANC-1 cells were Transfected with 10 nMmiR-486-5p antagonist and then exposed to 5-Fu for 48 hrs. Meanwhile, PANC-1 cells were transfected with 10 nMmiR-486-5p antagonist or exposed to 5-Fu for 48 hrs, respectively. Relative fluorescence expressions were quantified by Ki67 and DAPI staining. *P<0.05, **P<0.01 vs NC group; ##P<0.01 vs 5-FU group.